Cardinal Health Advanced Therapy Solutions

Kelly Kester, Director of Advanced Therapy Solutions 

Oct. 12 | 4:15pm | Oxford Biomedica Ballroom 

Dublin, OH 

(NASDAQ: CAH) 

In-person Presentation 

Cardinal Health Advanced Therapy Solutions brings a unique understanding of the challenges of launching and commercializing cell and gene therapies (CGTs) — and how to overcome them effectively. Our early involvement, starting with assisting biopharma in establishing the first CAR-T products in 2017, has enabled us to develop tailored solutions to simplify and streamline the complexities of CGTs. Our clinical and commercial capabilities across the product lifecycle, from regulatory consulting to cryopreservation and shipping, help biopharma companies manage more variables so they can focus on bringing their advanced therapy to patients. 

www.cardinalhealth.com 



By using this website you agree to accept our Privacy Policy and Terms & Conditions